This year, the FDA approved three drugs meant to prevent migraines and those, along with less expensive and less invasive techniques to stimulate the body’s response to pain through neurostimulation, are giving optimism to headache specialists and their patients after years of little progress.
from Kaiser Health News https://ift.tt/2zJIgSb
December 04, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Democrats Press High Court To Make Call On ACA. How It Could Play Out At Polls.You’re forgiven if in the holiday rush you missed the news last month that a federal appeals court in New Orleans once again put the future of the Affordable Care Act in doubt and ordered a lower court to review its fate. Or … Read More
FEMA Details U.S.’ Vulnerability To Natural Disasters, Terrorism’ In Annual ReportAdvocates decried the annual National Preparedness Report because it didn't mention climate change, which experts say exacerbated the deadly wildfires and storms of recent years. Other administration news focuses on water pol… Read More
Doctors Are Cashing In On Personal-Injury Suits By Treating Defendants And Hoping For Big Pay Out In EndThe practice of treating a defendant with no up front cost with the promise of getting paid once the suit settles. For some, that can mean a windfall of hundreds of thousands of dollars. from Kaiser Health News https://ift.t… Read More
First Edition: January 8, 2020Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/37NpLeo … Read More
Major Pharmacy Chains Claim Doctors, Other Providers Are Responsible For Opioid Crisis In New Lawsuit“The pharmacist is not supposed to be second guessing the medical necessity of the doctor’s prescription," said Timothy Johnson, an attorney for Discount Drug Mart. Walgreens, CVS, Rite Aid, Walmart and others who have found … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment